Movement Alert｜WuXi Biologics Rises 3.06% in Regular Trading, Sustained Buybacks and Sector Recovery Boost Share Price

Market Focus06-23

On June 23, WuXi Biologics rose 3.06% in regular trading, trading at HK$31.66/share, with turnover of HK$121 million.

On the news front, the company has been intensifying its share repurchase program. On June 22, the company spent approximately HK$49.24 million to buy back 1.6 million shares at prices between HK$30.66 and HK$31.14 per share. Earlier on June 18, it repurchased 3.26 million shares for approximately HK$99.74 million. Since the buyback authorization was approved at the shareholders meeting on June 10, the company has cumulatively repurchased over 11.5 million shares out of an authorized limit of approximately 412 million shares, signaling management confidence in the company's intrinsic value.

Meanwhile, the Life Sciences Tools and Services sector is broadly strengthening, with Insilico Medicine up 9.45%, XtalPi up 4.46%, WuXi XDC up 2.91%, GenScript Biotech up 2.36%, and WuXi AppTec up 1.28%. An industry-wide buyback wave among pharmaceutical companies continues to lift market sentiment, with sector valuation recovery expectations warming.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1145139736?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-23 10:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1145139736","market":"hk","top_or_hot":-1,"title":"Movement Alert｜WuXi Biologics Rises 3.06% in Regular Trading, Sustained Buybacks and Sector Recovery Boost Share Price","media":"Market Focus","content":"<p><p>On June 23, WuXi Biologics rose 3.06% in regular trading, trading at HK$31.66/share, with turnover of HK$121 million.</p><p>On the news front, the company has been intensifying its share repurchase program. On June 22, the company spent approximately HK$49.24 million to buy back 1.6 million shares at prices between HK$30.66 and HK$31.14 per share. Earlier on June 18, it repurchased 3.26 million shares for approximately HK$99.74 million. Since the buyback authorization was approved at the shareholders meeting on June 10, the company has cumulatively repurchased over 11.5 million shares out of an authorized limit of approximately 412 million shares, signaling management confidence in the company's intrinsic value.</p><p>Meanwhile, the Life Sciences Tools and Services sector is broadly strengthening, with Insilico Medicine up 9.45%, XtalPi up 4.46%, WuXi XDC up 2.91%, GenScript Biotech up 2.36%, and WuXi AppTec up 1.28%. An industry-wide buyback wave among pharmaceutical companies continues to lift market sentiment, with sector valuation recovery expectations warming.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜WuXi Biologics Rises 3.06% in Regular Trading, Sustained Buybacks and Sector Recovery Boost Share Price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜WuXi Biologics Rises 3.06% in Regular Trading, Sustained Buybacks and Sector Recovery Boost Share Price\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-23 10:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 23, WuXi Biologics rose 3.06% in regular trading, trading at HK$31.66/share, with turnover of HK$121 million.</p><p>On the news front, the company has been intensifying its share repurchase program. On June 22, the company spent approximately HK$49.24 million to buy back 1.6 million shares at prices between HK$30.66 and HK$31.14 per share. Earlier on June 18, it repurchased 3.26 million shares for approximately HK$99.74 million. Since the buyback authorization was approved at the shareholders meeting on June 10, the company has cumulatively repurchased over 11.5 million shares out of an authorized limit of approximately 412 million shares, signaling management confidence in the company's intrinsic value.</p><p>Meanwhile, the Life Sciences Tools and Services sector is broadly strengthening, with Insilico Medicine up 9.45%, XtalPi up 4.46%, WuXi XDC up 2.91%, GenScript Biotech up 2.36%, and WuXi AppTec up 1.28%. An industry-wide buyback wave among pharmaceutical companies continues to lift market sentiment, with sector valuation recovery expectations warming.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02269","symbol_name":"药明生物","start_time":0,"source_url":"","article_id":"1145139736","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1145139736","pubTimestamp":1782180140,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 23, WuXi Biologics rose 3.06% in regular trading, trading at HK$31.66/share, with turnover of HK$121 million.On the news front, the company has been intensifying its share repurchase program....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02269":"药明生物"},"translate_title":"动向提示|药明生物常规交易涨3.06%持续回购及板块回暖提振股价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02269":1},"content_text":"On June 23, WuXi Biologics rose 3.06% in regular trading, trading at HK$31.66/share, with turnover of HK$121 million.On the news front, the company has been intensifying its share repurchase program. On June 22, the company spent approximately HK$49.24 million to buy back 1.6 million shares at prices between HK$30.66 and HK$31.14 per share. Earlier on June 18, it repurchased 3.26 million shares for approximately HK$99.74 million. Since the buyback authorization was approved at the shareholders meeting on June 10, the company has cumulatively repurchased over 11.5 million shares out of an authorized limit of approximately 412 million shares, signaling management confidence in the company's intrinsic value.Meanwhile, the Life Sciences Tools and Services sector is broadly strengthening, with Insilico Medicine up 9.45%, XtalPi up 4.46%, WuXi XDC up 2.91%, GenScript Biotech up 2.36%, and WuXi AppTec up 1.28%. An industry-wide buyback wave among pharmaceutical companies continues to lift market sentiment, with sector valuation recovery expectations warming.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1145139736","isCrawlerRequest":true}